Get the content you want anytime you want.

Select coverage from ASM Microbe 2017 Conference is included below:

Why Clinicians Need to Know the Challenges Associated with Getting AST Results
ason Gallagher, PharmD, BCPS FCCP, FIDSA, explains why clinicians should be aware of the challenges associated with getting antimicrobial susceptibility testing results.
Treating <i>Pseudomonas</i>: How Does Ceftolozane-Tazobactam Differ from Other Beta-Lactams?
Jason Pogue, PharmD, BCPS-ID, explains how ceftolozane-tazobactam differs from other beta-lactams for treating Pseudomonas infections.
How to Remain Vigilant with Antimicrobial Shortages
Milena McLaughlin, PharmD, MSc, explains ways to remain vigilant when it comes to drug shortages.
Once Labeled, Always Labeled: Addressing Misconceptions About Penicillin Allergies
Elizabeth Phillips, MD, FRCPC, FRACP, addresses the misconceptions about penicillin allergies.
What is The Utility of Penicillin Skin Testing for Patients Labeled as Penicillin Allergic?
Meghan Jeffres, PharmD, discusses the utility of penicillin skin testing for patients labeled as penicillin allergic.
How Can Primary Care Providers Help Their Patients Decide if PrEP Is Right for Them?
Kenneth Mayer, MD, explains why primary care providers need to have a good sense of their patients in order to help them decide if PrEP is right for them.
Who Are the Core Partners Involved in the Fast-Track Cities Initiative?
Benjamin Young, MD, PhD, discusses the four partners behind the Fast-Track Cities Initiative.
Tenofovir Alafenamide: The Future of Pre-Exposure Prophylaxis?
Kenneth Mayer, MD, explains why tenofovir alafenamide may be the future of pre-exposure prophylaxis.
We break down our top HIV news stories of 2017. Did you read them all?